Interpace Diagnostics (IDXG) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Interpace Diagnostics (IDXG) Tops Q2 EPS by 2c

Interpace Diagnostics Group Reports Second Quarter 2018 Financial Results, Business Progress and Recent Accomplishments

August 9, 2018 4:47 PM EDT

Revenue Grew 43% Over the Prior Years Quarter and 14% Over the Prior Period

Record Quarterly Revenue of $5.5 Million

Cash & Cash Equivalents of $10.1 Million with No Long-Term Debt

Now Covered by 27 Regional Blue Cross/Blue Shield Plan for ThyGenX® and ThyraMIR®

Company Successfully Launched New Mutational Panel for Thyroid: ThyGeNEXT

Guidance of Revenues for the Year of Over $20 Million Reaffirmed

Conference Call Thursday August 9, 2018 at 4:30 pm ET

Parsippany, NJ, Aug. 09, 2018 (GLOBE NEWSWIRE) --... More